- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/06 - Inactivation or attenuationProducing viral sub-units by chemical treatment
Patent holdings for IPC class C12N 7/06
Total number of patents in this class: 119
10-year publication summary
|
8
|
10
|
10
|
9
|
11
|
7
|
13
|
3
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Valneva Austria GmbH | 119 |
9 |
| Valneva | 46 |
5 |
| Bharat Biotech International Limited | 84 |
4 |
| Serum Institute of India Private Limited | 106 |
4 |
| ACP Japan Co., Ltd. | 71 |
3 |
| Seqirus UK Limited | 432 |
3 |
| Shionogi & Co., Ltd. | 866 |
3 |
| Bayer HealthCare LLC | 1302 |
2 |
| National Institute of Advanced Industrial Science and Technology | 3794 |
2 |
| Novozymes A/S | 3361 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1431 |
2 |
| Elanco US Inc. | 723 |
2 |
| Takeda Vaccines, Inc. | 207 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
2 |
| Adcure Biotechnologies, LLC. | 3 |
2 |
| Solventum Intellectual Properties Company | 3370 |
2 |
| Alachua Government Services, Inc. | 18 |
2 |
| Boehringer Ingelheim International GmbH | 4494 |
1 |
| EMD Millipore Corporation | 634 |
1 |
| Bayer AG | 3470 |
1 |
| Other owners | 65 |